[go: up one dir, main page]

WO2009059047A3 - Tricyclic compounds and methods for using the same - Google Patents

Tricyclic compounds and methods for using the same Download PDF

Info

Publication number
WO2009059047A3
WO2009059047A3 PCT/US2008/081858 US2008081858W WO2009059047A3 WO 2009059047 A3 WO2009059047 A3 WO 2009059047A3 US 2008081858 W US2008081858 W US 2008081858W WO 2009059047 A3 WO2009059047 A3 WO 2009059047A3
Authority
WO
WIPO (PCT)
Prior art keywords
same
methods
tricyclic compounds
provides
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/081858
Other languages
French (fr)
Other versions
WO2009059047A2 (en
Inventor
Linda May Rothblum Watkins
Mark Rowland Hutchinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Colorado Boulder
Original Assignee
University of Colorado Boulder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Colorado Boulder filed Critical University of Colorado Boulder
Publication of WO2009059047A2 publication Critical patent/WO2009059047A2/en
Publication of WO2009059047A3 publication Critical patent/WO2009059047A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention provides tricyclic compounds of the formula: or a pharmaceutically acceptable salt or a pro-drug thereof, where R1, R2, X, Y, n, A, and B are those defined herein. The invention also provides compositions comprising the same, and methods for using the same.
PCT/US2008/081858 2007-10-30 2008-10-30 Tricyclic compounds and methods for using the same Ceased WO2009059047A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98392907P 2007-10-30 2007-10-30
US60/983,929 2007-10-30

Publications (2)

Publication Number Publication Date
WO2009059047A2 WO2009059047A2 (en) 2009-05-07
WO2009059047A3 true WO2009059047A3 (en) 2009-10-15

Family

ID=40591758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/081858 Ceased WO2009059047A2 (en) 2007-10-30 2008-10-30 Tricyclic compounds and methods for using the same

Country Status (1)

Country Link
WO (1) WO2009059047A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2545162T3 (en) * 2010-03-12 2017-02-06 Res Corp Tech Viable Gram Negative Bacteria Lacking Outer MEMBRANE AGONISTS FOR TLR4 / MD-2
CN106535901B (en) * 2014-03-12 2020-03-31 哥伦比亚大学董事会 Mu-opioid receptor agonists
CN108135866A (en) 2015-09-16 2018-06-08 哥伦比亚大学董事会 Carboxyl diaryl sulphur azepine amine is as μ-opioid receptor agonist
JP6893501B2 (en) * 2015-09-17 2021-06-23 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト Sulfinylphenyl or sulfonimideylphenyl benzazepine

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BOTNEY, M. ET AL.: "Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system", ANNALS OF NEUROLOGY, vol. 13, no. 2, 2004, pages 160 - 164 *
LYNCH, M.E.: "Antidepressants as analgesics: a review of randomized controlled tirals", JOURNAL OF PSYCHIATRY & NEUROSCIENCE, vol. 26, no. 1, 2001, pages 30 - 36 *
MARTIN, L. E. ET AL.: "Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies", JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, vol. 14, no. 2, 1997, pages 99 - 117 *
SACERDOTE, P. ET AL.: "A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, vol. 26, no. 1, 1987, pages 153 - 158 *
SAWYNOK, J. ET AL.: "Antidepressants as analgesics: an overview of central and peripheral mechanisms of action", JOURNAL OF PSYCHIATRY & NEUROSCIENCE, vol. 26, no. 1, 2001, pages 21 - 29 *
VALVERDE, O ET AL.: "Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice", PROGRESS IN NEUROPSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 18, no. 6, 1994, pages 1073 - 1092 *

Also Published As

Publication number Publication date
WO2009059047A2 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
UA94833C2 (en) Substituted bicyclolactams
WO2008115516A3 (en) 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
WO2008083248A3 (en) Cyclopamine analogs
WO2006050161A3 (en) Therapeutic furopyrimidines and thienopyrimidines
WO2007002559A8 (en) Pyrazole based lxr modulators
WO2006039164A3 (en) Novel cyclosporin analogues and their pharmaceutical uses
WO2008039489A3 (en) 5-substituted quinazolinone derivatives as antitumor agents
WO2008005542A3 (en) Antiviral phosphinate compounds
WO2007028135A3 (en) Imidazopyridine compounds
WO2008044243A3 (en) Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
WO2008096001A8 (en) Hcv inhibiting macrocyclic phenylcarbamates
WO2009025876A3 (en) Crystalline forms of erlotinib hcl and formulations thereof
WO2007143523A3 (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
WO2005094329A3 (en) Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
WO2007103762A3 (en) Compositions and methods of use of electron transport system inhibitors
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2007112913A3 (en) Benzimidazole derivatives
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
WO2009059047A3 (en) Tricyclic compounds and methods for using the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845403

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08845403

Country of ref document: EP

Kind code of ref document: A2